Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region

BACKGROUND: Most patients treated with erenumab in clinical practice have chronic migraine (CM). We assessed the rate and possible predictors of conversion from CM to episodic migraine (EM) in a real-life study. MAIN BODY: We performed a subgroup analysis of patients treated with erenumab from Janua...

Descripción completa

Detalles Bibliográficos
Autores principales: Ornello, Raffaele, Casalena, Alfonsina, Frattale, Ilaria, Caponnetto, Valeria, Gabriele, Amleto, Affaitati, Giannapia, Giamberardino, Maria Adele, Assetta, Maurizio, Maddestra, Maurizio, Marzoli, Fabio, Viola, Stefano, Cerone, Davide, Marini, Carmine, Pistoia, Francesca, Sacco, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429460/
https://www.ncbi.nlm.nih.gov/pubmed/32799790
http://dx.doi.org/10.1186/s10194-020-01171-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429460/
https://www.ncbi.nlm.nih.gov/pubmed/32799790
http://dx.doi.org/10.1186/s10194-020-01171-w

Ejemplares similares